Last $0.15 USD
Change Today 0.00 / 0.00%
Volume 0.0
PARD On Other Exchanges
Symbol
Exchange
OTC US
Stuttgart
As of 8:10 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael S. Perry DVM, Ph.D., FACVPT

AgeTotal Calculated CompensationThis person is connected to 45 board members in 6 different organizations across 9 different industries.

See Board Relationships
55--

Background*

Dr. Michael S. Perry, DVM, Ph.D., FACVPT, served as Vice President and Senior Global Program Head of Stem Cell Therapy at Novartis Pharmaceuticals Corporation. Dr. Perry was a Venture Partner at Bay City Capital LLC from 2005 to 2012. He has been Consultant at Poniard Pharmaceuticals, Inc since September 2009 and served as its President and Chief Medical Officer from February 5, 2010 to March 31, 2012. He served as the Chief Development Officer at VIA Pharmaceuticals ...

Read Full Background

Corporate Headquarters*

300 Elliott Avenue West
Seattle, Washington 98119

United States

Phone: 206-281-7001
Fax: 206-284-3181

Board Members Memberships*

Director
Former Chairman
1999-Present
Director
2002-N/A
Former Chief Executive Officer, President and Director
2005-Present
Independent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2007-Present
Chairman, Chairman of Audit Committee, Chairman of Nominating Committee and Chairman of Compensation Committee
2011-Present
Director, Chairman of Compensation Committee, Chairman of Nomination Committee and Member of Audit Committee
2013-Present
Non-Executive Director and Member of Remuneration Committee

Education*

Doctorate
University Of Guelph
PhD
University Of Guelph
BS
University Of Guelph
Unknown/Other Education
Harvard Business School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PARD:US $0.15 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PONIARD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.